"Kartal Dr. Lütfi Kırdar Şehir Hastanesi"

During the past decade, Kartal Lutfi Kirdar Research and Training Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 2 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kartal Lutfi Kirdar Research and Training Hospital" #1 sponsor was "Dr. Lutfi Kirdar Kartal Training and Research Hospital" with 4 trials, followed by "Health Institutes of Turkey" with 3 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kartal Lutfi Kirdar Research and Training Hospital" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Kartal Lutfi Kirdar Research and Training Hospital" are "COVID-19" (2 trials), "Covid19" (2 trials), "Sars-CoV-2 Infection" (2 trials), "Acute Renal Failure" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Kartal Lutfi Kirdar Research and Training Hospital" in a lesser frequency.

Most popular intervention types in "Kartal Lutfi Kirdar Research and Training Hospital" are "Drug" (5 trials), "Biological" (3 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "CoronaVac" (2 trials), "Turkovac" (2 trials), "Anesthesia method" (1 trials) and "Avelumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kartal Lutfi Kirdar Research and Training Hospital" are 10 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Kartal Lutfi Kirdar Research and Training Hospital". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 6 completed trials in Kartal Lutfi Kirdar Research and Training Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kartal Lutfi Kirdar Research and Training Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".